BMY Sentiment Analysis
We collect and analyze sentiment surrounding BMY stock to help you make informed investment decisions.
BRISTOL-MYERS SQUIBB COMPANY Hits Price Target Forecast with 11.1% Profit Achieved
Published on July 31, 2025
On April 16, 2025, QuantWave issued a short forecast signal for BRISTOL-MYERS SQUIBB COMPANY with a price of 48.72 $....
BRISTOL-MYERS SQUIBB COMPANY Stock Hits Forecast Price Target with 10.86% Profit
Published on July 31, 2025
QuantWave, an automated forecasting platform, recently achieved a milestone in its prediction accuracy with the successful forecast of BRISTOL-MYERS SQUIBB COMPANY's stock movement. The forecast signal date of April 17, 2025, indicating a short posit...
Bristol Myers Squibb NYSE:BMY Set to Revolutionize Cancer Treatment with Breakthrough Drug
Published on June 23, 2025
Bristol Myers Squibb Company, a leading pharmaceutical company, is on the verge of revolutionizing cancer treatment with its groundbreaking new drug. The drug has shown promising results in clinical trials, offering hope to millions of patients world...
BMY: Bristol-Myers Squibb Co. Reports Positive Phase 3 Trial Results For Sotyktu
Published on June 12, 2025
Investors are taking notice of Bristol-Myers Squibb Company, as they have recently announced positive phase 3 trial results for their drug Sotyktu. This news has caused BMY shares to rise by 3.07% on June 10, capturing the attention of many in the ma...
QuantWave Successfully Achieves Price Target Forecast for Bristol-Myers Squibb Company with 14.06% Profit
Published on May 14, 2025
QuantWave, an automated forecasting platform, recently celebrated a significant achievement in its analytics with the successful price target forecast for the stock of BRISTOL-MYERS SQUIBB COMPANY. The forecast signal was initiated on April 14, 2025,...
BRISTOL-MYERS SQUIBB COMPANY Hits QuantWave Price Target with 13.0% Profit Margin
Published on May 14, 2025
On April 11, 2025, QuantWave, an automated forecasting platform, released a short signal for BRISTOL-MYERS SQUIBB COMPANY with a price target forecast of 44.12 $, indicating a 13.0% profit margin from the initial price of 50.71 $. Remarkably, this ta...
BRISTOL-MYERS SQUIBB COMPANY Stock Hits Price Target with 9.09% Profit: QuantWave Forecast Success
Published on May 14, 2025
On April 23, 2025, QuantWave's forecasting platform generated a short signal for BRISTOL-MYERS SQUIBB COMPANY stock, which was trading at $47.9 at the time. The predicted direction pointed towards a decrease in the stock price. Fast forward to May 14...
BRISTOL-MYERS SQUIBB COMPANY Hits Price Target Forecast with 12.75% Profit - QuantWave Analysis
Published on May 14, 2025
BRISTOL-MYERS SQUIBB COMPANY recently achieved the price target forecast set by QuantWave, resulting in a profitable outcome of 12.75%. The forecast signal was initiated on 2025-05-02 with a price of 49.91 $ and a predicted direction of short. On 202...
BRISTOL-MYERS SQUIBB COMPANY Hits Price Target Forecast with 11.87% Profit
Published on May 14, 2025
On May 5, 2025, QuantWave issued a short signal for BRISTOL-MYERS SQUIBB COMPANY when the stock was trading at $49.41....
BRISTOL-MYERS SQUIBB COMPANY Hits Price Target Forecast with 11.76% Profit
Published on May 14, 2025
On April 15, 2025, QuantWave, the automated forecasting platform, issued a short signal for BRISTOL-MYERS SQUIBB COMPANY when the stock was trading at $49.35. Analysts predicted a downward movement in the stock price. Fast forward to May 14, 2025, an...
BRISTOL-MYERS SQUIBB COMPANY Stock Hits Target Forecast with 13.0% Profit - QuantWave Analysis
Published on May 14, 2025
On April 11, 2025, QuantWave, the automated forecasting platform, issued a short signal for BRISTOL-MYERS SQUIBB COMPANY with a price of $50.05. The prediction was spot on as on May 14, 2025, the stock reached the target price of $43.55, resulting in...
BRISTOL-MYERS SQUIBB COMPANY Hits Price Target Forecast with 10.38% Profit: QuantWave Analysis
Published on May 14, 2025
BRISTOL-MYERS SQUIBB COMPANY, a renowned pharmaceutical company, recently achieved its price target forecast set by QuantWave's automated forecasting platform. The forecast signal was issued on 2025-04-17 when the stock was trading at 48.59 $. The pr...
BRISTOL-MYERS SQUIBB COMPANY Hits Price Target Forecast with 14.06% Profit
Published on May 14, 2025
On April 14, 2025, QuantWave's forecast signal indicated a short position for BRISTOL-MYERS SQUIBB COMPANY stock, which was priced at 50.67 $. Fast forward to May 14, 2025, the predicted target was met with the stock reaching 43.55 $, resulting in a ...
QuantWave Forecast Accuracy: BRISTOL-MYERS SQUIBB Hits Price Target with 9.85% Profit
Published on May 14, 2025
On April 21, 2025, QuantWave, an automated forecasting platform, issued a short signal for the stock of BRISTOL-MYERS SQUIBB COMPANY when it was trading at $48.3. The platform's prediction proved accurate as the stock reached the target price of $43....
BRISTOL-MYERS SQUIBB COMPANY Hits Price Target as QuantWave Forecast Achieves 7.55% Profit
Published on May 8, 2025
BRISTOL-MYERS SQUIBB COMPANY has seen its stock reach the predicted price target set by QuantWave's automated forecasting platform. The forecast signal date of 2025-04-11 indicated a short direction with the stock priced at 50.71 $. On 2025-05-08, th...
BRISTOL-MYERS SQUIBB COMPANY Hits Forecast Target with 8.57% Profit: A Success Story for QuantWave
Published on April 10, 2025
BRISTOL-MYERS SQUIBB COMPANY (BMY) recently reached the price target forecasted by QuantWave, resulting in a profitable outcome for investors. The forecast signal, issued on February 20, 2025, indicated a short position with the stock trading at $55....
BRISTOL-MYERS SQUIBB COMPANY Hits Price Target Forecast with 8.64% Profit: QuantWave Analysis
Published on April 10, 2025
BRISTOL-MYERS SQUIBB COMPANY, a leading pharmaceutical company, recently saw its stock reach the price target forecasted by QuantWave, generating an impressive 8.64% profit for investors. The forecast signal, issued on February 21, 2025, indicated a ...
QuantWave Successfully Forecasts Price Target for Bristol-Myers Squibb, Profiting 8.57%
Published on April 10, 2025
On February 20, 2025, QuantWave, the automated forecasting platform, issued a short signal for BRISTOL-MYERS SQUIBB COMPANY when the stock was trading at 54.47 $. The prediction proved accurate as the target price of 49.8 $ was reached on April 10, 2...
QuantWave Nails Forecast for BRISTOL-MYERS SQUIBB COMPANY with 8.64% Profit
Published on April 10, 2025
QuantWave, a leading automated forecasting platform, recently achieved great success with its price target forecast for BRISTOL-MYERS SQUIBB COMPANY. The forecast signal was issued on February 21, 2025, with a price of $54.51 and a predicted short di...
Market Update: Bristol Myers Squibb (BMY) Ascends But Remains Behind Market: Some Facts to Note
Published on March 21, 2025
Bristol Myers Squibb (BMY) has seen a recent upswing in its stock price, but it still lags behind the overall market....
Is Bristol-Myers Squibb the Most Undervalued Biotech Company?
Published on March 20, 2025
Recently, the European Commission (EC) has given its approval to Breyanzi, a novel treatment developed by Bristol-Myers Squibb (BMS) for Non-Hodgkin's Lymphoma (NHL). This represents a significant milestone for the company, as it expands its portfoli...
Positive Development for Bristol-Myers Squibb Company's Breyanzi NHL Treatment
Published on March 19, 2025
Bristol-Myers Squibb Company's groundbreaking NHL treatment, Breyanzi, has received approval from the European Commission (EC) for its use in patients. This approval is a significant milestone for the pharmaceutical company as it expands its reach in...
Is Bristol-Myers Squibb Company BMY the Best Pharma Stock to Buy According to Hedge Funds
Published on March 18, 2025
Bristol-Myers Squibb Company (BMY) has gained the attention of hedge funds as the best pharmaceutical stock to invest in....
Why Bristol-Myers Squibb Company BMY Went Down On Friday
Published on March 17, 2025
Bristol-Myers Squibb Company (BMY) experienced a decline in their stock price on Friday....
Is Bristol-Myers Squibb Company BMY The Best Cheap Dividend Stock To Buy Right Now?
Published on March 14, 2025
Recently, Bristol-Myers Squibb Company (BMY) has gained attention as a potentially lucrative investment opportunity....